Aim: The aim was to assess the clinical impact of direct-acting antiviral treatment in patients with compensated hepatitis C virus-related cirrhosis after one year of follow-up.Methods: An observational retrospective study was conducted on 129 consecutive patients with compensated cirrhosis treated in 2015, analyzing the evolution of liver function and the development of hepatocellular carcinoma and clinical decompensations.Results: The median follow-up time was 16 months. Most patients were males (73%), the mean age was 58.1 years and the most frequent genotype was 1b (52.2%). All participants were Child-Pugh A class at the start of the treatment and the median model for end-stage liver disease (MELD) score was 7. Four patients (4.4%) suff...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
Aim: The aim was to assess the clinical impact of direct-acting antiviral treatment in patients with...
AIM: To study the outcomes of patients with compensated hepatitis C virus-related cirrhosis. METHODS...
AIM: To study the outcomes of patients with compensated hepatitis C virus-related cirrhosis. METHODS...
AIM: To study the outcomes of patients with compensated hepatitis C virus-related cirrhosis. METHODS...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
Background and Aims Direct-acting antivirals have become widely used for patients with chronic hepat...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
Aim: The aim was to assess the clinical impact of direct-acting antiviral treatment in patients with...
AIM: To study the outcomes of patients with compensated hepatitis C virus-related cirrhosis. METHODS...
AIM: To study the outcomes of patients with compensated hepatitis C virus-related cirrhosis. METHODS...
AIM: To study the outcomes of patients with compensated hepatitis C virus-related cirrhosis. METHODS...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
Background and Aims Direct-acting antivirals have become widely used for patients with chronic hepat...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...
International audienceBACKGROUND: In HCV-infected patients with advanced liver disease, the direct a...